Previously Untreated Acute Myeloid Leukemia With An Idh1 Mutation clinical trials

Explore recruiting previously untreated acute myeloid leukemia with an idh1 mutation clinical trials.

Also recruiting in Europe

Previously Untreated Acute Myeloid Leukemia With An Idh1 Mutation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of AG-120 in Combination with Azacitidine in Subjects ≥18 Years of Age with Previously Untreated Acute Myeloid Leukemia with an IDH1 Mutation

Spain, Poland, Germany, France, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Previously Untreated Acute Myeloid Leukemia With An Idh1 Mutation trials by city

Previously Untreated Acute Myeloid Leukemia With An Idh1 Mutation in Toronto Previously Untreated Acute Myeloid Leukemia With An Idh1 Mutation in Vancouver Previously Untreated Acute Myeloid Leukemia With An Idh1 Mutation in Montreal Previously Untreated Acute Myeloid Leukemia With An Idh1 Mutation in Calgary Previously Untreated Acute Myeloid Leukemia With An Idh1 Mutation in Edmonton Previously Untreated Acute Myeloid Leukemia With An Idh1 Mutation in Ottawa Previously Untreated Acute Myeloid Leukemia With An Idh1 Mutation in Winnipeg Previously Untreated Acute Myeloid Leukemia With An Idh1 Mutation in Quebec City Previously Untreated Acute Myeloid Leukemia With An Idh1 Mutation in Hamilton Previously Untreated Acute Myeloid Leukemia With An Idh1 Mutation in Kitchener Previously Untreated Acute Myeloid Leukemia With An Idh1 Mutation in London Previously Untreated Acute Myeloid Leukemia With An Idh1 Mutation in Halifax Previously Untreated Acute Myeloid Leukemia With An Idh1 Mutation in New York Previously Untreated Acute Myeloid Leukemia With An Idh1 Mutation in Los Angeles Previously Untreated Acute Myeloid Leukemia With An Idh1 Mutation in Chicago Previously Untreated Acute Myeloid Leukemia With An Idh1 Mutation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease